Xenetic Biosciences, Inc. Contracts & Agreements
134 Contracts & Agreements
- Business Finance (67 contracts)
- Business Operations (17)
- Human Resources (6)
- Intellectual Property (7)
- Real Estate (2)
- Uncategorized (35)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 21, 2024)
- Research Funding and Option Agreement, dated March 17, 2023, between the Company and the Scripps Research Institute (Filed With SEC on May 11, 2023)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 22, 2023)
- Exclusive Sublicense Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)
- Exclusive License Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)
- Form of Subscription Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)
- Statement of Work, dated June 30, 2022, between Xenetic Biosciences, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on August 11, 2022)
- Novation of Agreement on Co-Development and the Terms of Exclusive License, dated December 17, 2021, between Xenetic Biosciences (UK) Limited (formerly Lipoxen plc), Lipoxen... (Filed With SEC on March 22, 2022)
- Exclusive License Agreement, dated December 20, 2021, between Lipoxen Technologies Limited and Public Joint-Stock Company Pharmsynthez (Filed With SEC on March 22, 2022)
- Amendment Number One to the Master Services Agreement, dated October 12, 2021, between the Company and PJSC Pharmsynthez (Filed With SEC on March 22, 2022)
- Second Work Order to Master Service Agreement, dated October 12, 2021, between the Company and PJSC Pharmsynthez (Filed With SEC on March 22, 2022)
- At The Market Offering Agreement by and between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated November 19, 2021 (Filed With SEC on November 19, 2021)
- Form of Letter Agreement by and between Xenetic Biosciences, Inc. and the Holders, dated November 15, 2021 (Filed With SEC on November 16, 2021)
- Form of Series A Warrant (Filed With SEC on July 28, 2021)
- Form of Series B Warrant (Filed With SEC on July 28, 2021)
- Form of Securities Purchase Agreement, dated July 26, 2021, by and among the Company and the other parties thereto (Filed With SEC on July 28, 2021)
- Form of Registration Rights Agreement, dated July 26, 2021, by and among the Company and the other parties thereto (Filed With SEC on July 28, 2021)
- Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of July 25, 2021 (Filed With SEC on July 28, 2021)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2021)
- Form of Securities Purchase Agreement between Xenetic Biosciences, Inc. and the purchasers named therein, dated as of December 10, 2020 (Filed With SEC on December 14, 2020)
- Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of December 9, 2020 (Filed With SEC on December 14, 2020)
- Research Funding and Option Agreement, dated May 15, 2020, between the Company and the Scripps Research Institute (Filed With SEC on August 12, 2020)
- Master Service Agreement, dated June 12, 2020, between the Company and PJSC Pharmsynthez (Filed With SEC on August 12, 2020)
- Work Order to Master Service Agreement, dated June 12, 2020, between the Company and PJSC Pharmsynthez (Filed With SEC on August 12, 2020)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 26, 2020)
- Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Grigory G. Borisenko, effective as of September 26, 2019 (Filed With SEC on March 26, 2020)
- Form of Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc (Filed With SEC on March 26, 2020)
- Form of Xenetic Biosciences, Inc. Stock Option Grant Notice (Filed With SEC on March 26, 2020)
- Xenetic Biosciences, Inc. Stock Option Grant Notice, dated December 4, 2019, between Jeffrey Eisenberg and Xenetic Biosciences, Inc (Filed With SEC on March 26, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on July 22, 2019)
- Form of Purchase Warrant (Filed With SEC on July 22, 2019)
- Warrant Agency Agreement (Filed With SEC on July 22, 2019)
- Underwriting Agreement (Filed With SEC on July 22, 2019)
- Third Amendment to the Share Purchase Agreement (Filed With SEC on July 16, 2019)
- Third Amendment to the OPKO Assignment Agreement (Filed With SEC on July 16, 2019)
- Consent Agreement (Filed With SEC on July 16, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on July 12, 2019)
- Form of Purchase Warrant (Filed With SEC on July 12, 2019)
- Form of Underwriting Agreement (Filed With SEC on July 2, 2019)
- Form of Purchase Warrant (Filed With SEC on July 2, 2019)
- Form of Warrant (Filed With SEC on June 25, 2019)
- CONSENT AGREEMENT (Filed With SEC on June 25, 2019)
- Second Amendment to the Share Purchase Agreement (Filed With SEC on June 24, 2019)
- Second Amendment to the OPKO Assignment Agreement (Filed With SEC on June 24, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on June 24, 2019)
- Form of Purchase Warrant (Filed With SEC on June 24, 2019)
- First Amendment to the Share Purchase Agreement (Filed With SEC on June 13, 2019)
- First Amendment to the OPKO Assignment Agreement (Filed With SEC on June 13, 2019)
- OPKO Assignment Agreement (Filed With SEC on May 20, 2019)
- OPKO Assignment Agreement (Filed With SEC on May 13, 2019)
- Share Purchase Agreement (Filed With SEC on May 13, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on March 7, 2019)
- Form of Purchase Warrant (Filed With SEC on March 7, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on March 7, 2019)
- OPKO Assignment Agreement (Filed With SEC on March 4, 2019)
- Voting Agreement Pharmsynthez (Filed With SEC on March 4, 2019)
- Voting Agreement OPKO (Filed With SEC on March 4, 2019)
- Voting Agreement Dr. Genkin (Filed With SEC on March 4, 2019)
- Share Purchase Agreement (Filed With SEC on March 4, 2019)
- Amended and Restated Employment Agreement, dated October 26, 2017, between Xenetic Biosciences, Inc. and Jeffrey Eisenberg (Filed With SEC on March 30, 2018)
- Right to Sublicense Agreement, dated October 27, 2017, by and among Xenetic Biosciences, Inc., Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH (Filed With SEC on March 30, 2018)
- Settlement Agreement, dated November 3, 2017, by and among M. Scott Maguire, Xenetic Biosciences (UK) Limited and Lipoxen Technologies, Limited (Filed With SEC on March 30, 2018)
- Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Adam Logal dated October 11, 2017 (Filed With SEC on March 30, 2018)
- Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for James E. Callaway dated October 11, 2017 (Filed With SEC on March 30, 2018)
- Form of Indemnity Agreement by and between the Registrant and each of its directors and executive officers (Filed With SEC on August 14, 2017)
- XENETIC BIOSCIENCES INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 4, 2017)
- XeneticBiosciences, Inc. Stock Option Grant Notice (InducementAward) (Filed With SEC on April 4, 2017)
- Employment Agreement (Filed With SEC on January 4, 2017)
- Employment Agreement (Filed With SEC on December 6, 2016)
- Directors Letter Agreement (Filed With SEC on November 22, 2016)
- COMMON STOCK PURCHASE WARRANT XENETIC BIOSCIENCES,INC. (Filed With SEC on October 31, 2016)
- XENETIC BIOSCIENCES, INC. SHAREHOLDER VOTING AGREEMENT (Filed With SEC on October 27, 2016)
- UNDERWRITING AGREEMENT between XENETIC BIOSCIENCES, INC. and LadenburgThalmann & Co. Inc. (Filed With SEC on October 11, 2016)
- COMMON STOCK PURCHASE WARRANT XENETIC BIOSCIENCES, INC. (Filed With SEC on October 11, 2016)
- AGREEMENT OF EXCHANGE (Filed With SEC on September 23, 2016)
- UNDERWRITING AGREEMENT between XENETIC BIOSCIENCES, INC. and LadenburgThalmann & Co. Inc. (Filed With SEC on July 14, 2016)
- Directors Letter Agreement (Filed With SEC on July 12, 2016)
- DEFERREDSALARY SECURITY AGREEMENT (Filed With SEC on July 8, 2016)
- TENPERCENT (10%) JUNIOR SECURED COLLATERALIZED CONVERTIBLEPROMISSORY NOTE DueDeferral end date (Filed With SEC on July 8, 2016)
- COMMON STOCK PURCHASE WARRANT XENETICBIOSCIENCES, INC. (Filed With SEC on July 8, 2016)
- Directors Letter Agreement (Filed With SEC on February 29, 2016)
- FORM OF ASSET PURCHASE AGREEMENT among AS KEVELT, OJSC PHARMSYNTHEZ and XENETIC BIOSCIENCES, INC. and LIPOXEN TECHNOLOGIES, LTD. dated as of NOVEMBER 13, 2015 (Filed With SEC on November 16, 2015)
- FORMOF TENPERCENT (10%) SENIOR SECURED COLLATERALIZED CONVERTIBLEPROMISSORY NOTE DUE________________ (Filed With SEC on November 16, 2015)
- FORM OF COMMON STOCK PURCHASE WARRANT XENETICBIOSCIENCES, INC. (Filed With SEC on November 16, 2015)
- FORM OF COMMON STOCK PURCHASE WARRANT XENETICBIOSCIENCES, INC. (Filed With SEC on November 16, 2015)
- FORM OF AMENDEDAND RESTATED TENPERCENT (10%) SENIOR SECURED COLLATERALIZED CONVERTIBLEPROMISSORY NOTE DUEOctober 1, 2016 (Filed With SEC on November 16, 2015)
- FORM OF COMMON STOCK PURCHASE WARRANT XENETICBIOSCIENCES, INC. (Filed With SEC on November 16, 2015)
- FORM OF FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 16, 2015)
- FORM OF FIRST AMENDMENT TO REGISTRATION RIGHTSAGREEMENT (Filed With SEC on November 16, 2015)
- FORM OF FIRST AMENDMENT TO SECURITYAGREEMENT (Filed With SEC on November 16, 2015)
- FORM OF FIRST AMENDMENT TO SUBSIDIARYGUARANTEE (Filed With SEC on November 16, 2015)
- FORM OF Transition, Services and ResupplyAgreement # 15-8-311 by and among AS Kevelt, OJSC Pharmsynthez and Xenetic Biosciences, Inc. (Filed With SEC on November 16, 2015)
- Dated 27 August 2015 XENETIC BIOSCIENCES (UK) LIMITED and LIPOXEN TECHNOLOGIES LIMITED and COLIN HILL and XENETIC BIOSCIENCES INC SETTLEMENT AGREEMENT Without prejudice and... (Filed With SEC on September 2, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 8, 2015)
- TEN PERCENT (10%) SENIOR SECURED COLLATERALIZED CONVERTIBLE PROMISSORY NOTE DUE July 1, 2016 (Filed With SEC on July 8, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 8, 2015)
- SECURITY AGREEMENT (Filed With SEC on July 8, 2015)
- SUBSIDIARY GUARANTEE (Filed With SEC on July 8, 2015)
- COMMON STOCK PURCHASEWARRANT XENETIC BIOSCIENCES,INC. (Filed With SEC on July 8, 2015)
- ASSIGNMENTAND ASSUMPTION AGREEMENT (Filed With SEC on July 8, 2015)
- Dated 2014 (1)DIMITRY GENKIN AND (2)FDS PHARMA AND (3)LIPOXEN TECHNOLOGIES LIMITED AND (4)XENETIC BIOSCIENCES INC INTELLECTUALPROPERTY ASSIGNMENT KEYSTONE LAW 53 Davies... (Filed With SEC on April 15, 2015)
- WARRANT TO PURCHASE COMMONSTOCK OF XENETIC BIOSCIENCES,INC. Void afterDecember 30, 2019 Date of Issuance:December 31, 2014 (Filed With SEC on April 15, 2015)
- WARRANT TO PURCHASE COMMONSTOCK OF XENETIC BIOSCIENCES,INC. Void afterDecember 30, 2019 Date ofIssuance: December 31, 2014 (Filed With SEC on April 15, 2015)
- WARRANT TO PURCHASE COMMONSTOCK OF XENETIC BIOSCIENCES,INC. Void afterDecember 30, 2019 Date ofIssuance: December 31, 2014 (Filed With SEC on April 15, 2015)
- Agreement with Mark Leuchtenberger (Filed With SEC on May 6, 2014)
- XENETIC BIOSCIENCES, INC. EQUITYINCENTIVE PLAN Effective January 23, 2014 XENETIC BIOSCIENCES, INC. EQUITY INCENTIVE PLAN ARTICLE I PURPOSE (Filed With SEC on April 15, 2014)
- [***] (Filed With SEC on April 15, 2014)
- AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (Filed With SEC on April 15, 2014)
- EXCLUSIVE RESEARCH, DEVELOPMENT AND LICENSEAGREEMENT (Filed With SEC on April 15, 2014)
- 200500453-11412 (Filed With SEC on April 15, 2014)
- AMENDMENT (Filed With SEC on April 15, 2014)
- SECOND AMENDMENT TO EXCLUSIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on April 15, 2014)
- DATED AUGUST, 10 2010 LIPOXEN TECHNOLOGIES, LTD. - and - BAXTERHEALTHCARE CORPORATION AND BAXTER HEALTHCARE SA AMENDMENT NUMBER FOUR TO THE EXCLUSIVE RESEARCH, DEVELOPMENT AND... (Filed With SEC on April 15, 2014)
- DATED SEPTEMBER, 15 2010 LIPOXEN TECHNOLOGIES, LTD. - and - BAXTERHEALTHCARE CORPORATION AND BAXTER HEALTHCARE SA AMENDMENT NUMBER FIVE TO THE EXCLUSIVE RESEARCH, DEVELOPMENT AND... (Filed With SEC on April 15, 2014)
- SIXTH AMENDMENT TO THE EXCLUSIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on April 15, 2014)
- MASTER CLINICAL RESEARCH SERVICES AGREEMENT (Filed With SEC on April 15, 2014)
- 4 August 2011 AGREEMENT ON CO-DEVELOPMENT AND THE TERMS OF EXCLUSIVE LICENCE between (1) LIPOXENPLC (2) LIPOXEN TECHNOLOGIES LTD - and- (3) SYNBIO LLC (Filed With SEC on April 15, 2014)
- DATED 4 August 2011 (1) SynBio LLC (2) Lipoxen Plc SUBSCRIPTION AGREEMENT in respect of ordinary shares inthe capital of Lipoxen plc (Filed With SEC on April 15, 2014)
- (1)LIPOXEN TECHNOLOGIES LTD - and - (2) PHARMASYNTHEZ ZAO COLLABORATION, LICENCE AND DEVELOPMENT AGREEMENT (Filed With SEC on April 15, 2014)
- (1) LIPOXEN PLC (2)LIPOXEN TECHNOLOGIES LTD - and - (2) SERUM INSTITUTE OF INDIA LIMITED ExclusivePatent And Know How Licence and Manufacturing Agreement (Filed With SEC on April 15, 2014)
- DATED 23 JANUARY 2014 (1) SYNBIOLLC and (2) XENETIC BIOSCIENCES,INC. (PREVIOUSLY GENERAL SALES AND LEASING, INC.) DIRECTOR APPOINTMENTAGREEMENT 1 (Filed With SEC on April 15, 2014)
- DATED: 3 November 2009 (1) LIPOXEN PLC - and- (2) MICHAEL SCOTT MAGUIRE SERVICEAGREEMENT (Filed With SEC on April 15, 2014)
- 2 July 2007 (1) LIPOXENPLC - and - (2) COLIN HILL SERVICEAGREEMENT 1 (Filed With SEC on April 15, 2014)
- XENETIC BIOSCIENCE, INCORPORATED LEDGEMONT RESEARCH CENTER LEXINGTON, MA (Filed With SEC on April 15, 2014)
- The Crown Estate 16 New Burlington Place London W1S2HX TABLE OF CONTENTS (Filed With SEC on April 15, 2014)
- DATED 18th JULY 2000 RULES OF THE LIPOXENPLC UNAPPROVED SHARE OPTION PLAN (as amended by a resolution of the board of directors of Lipoxen PLC passed on 14 March 2006) 17... (Filed With SEC on April 15, 2014)
- XENETIC BIOSCIENCES PLC 2007 SHARE OPTION SCHEME AND US ADDENDUM (ASESTABLISHED IN 2007 AND BY RESOLUTION OF SHAREHOLDERS IN 2010 AND AWARDED BY BOARD RESOLUTION IN 2012) XENETIC... (Filed With SEC on April 15, 2014)
- Agreement with Dr. Timothy R. Cot (Filed With SEC on February 10, 2014)
- Order of the High Court of Justice, Chancery Division, entered January 23, 2014 (Filed With SEC on January 29, 2014)
- Helicopter Lease Agreement with Coast Flight Academy (Filed With SEC on January 21, 2014)
- Financing and Security Agreement with North Star Capital Group, Inc (Filed With SEC on November 27, 2013)
- Helicopter Lease Agreement (Filed With SEC on December 14, 2012)
- Aircraft Use / Management Agreement (Filed With SEC on November 21, 2011)
- Promissory Note and Security Agreement (Filed With SEC on November 21, 2011)